Target intelligence / Profile preview

Oxaloacetate (OAA)

Target
OAA
Molecular classification
Metabolite, Organic compound (short-chain keto acids and derivatives), Metabolic intermediate
01

Overview

Oxaloacetate (OAA), also known as oxaloacetic acid, is a four-carbon dicarboxylic keto-acid that serves as an essential metabolic intermediate within living organisms. Its chemical formula is C₄H₄O₅ (or C₄H₂O₅²⁻ when deprotonated). OAA plays pivotal roles across several fundamental biochemical pathways: * Citric Acid Cycle: OAA condenses with acetyl-CoA to form citrate—the first step of the TCA/Krebs/citric acid cycle—which drives cellular ATP production through oxidative phosphorylation. * Gluconeogenesis: In this pathway, OAA acts as an intermediary between pyruvate and phosphoenolpyruvate during glucose synthesis. * Amino Acid Synthesis: Through transamination reactions, it forms amino acids such as aspartic acid. * Fatty Acid Synthesis & Urea Cycle: Participates indirectly by providing intermediates required for these processes. * Regulation of Energy Metabolism: The availability of OAA can regulate flux through the citric acid cycle and thus influence overall cellular energy status.[1][2][4] While crucial to life’s biochemistry, oxaloacetate does not function like traditional drug targets such as receptors or enzymes but instead acts primarily by serving structural and regulatory roles within core metabolic networks. No approved therapeutics act directly on this molecule; rather, interventions may affect upstream or downstream enzymes influencing its concentration.[1]

Other names
Oxaloacetic acidOxalacetic acid2-oxobutanedioic acidα-ketosuccinic acidKetosuccinate2-Ketosuccinic acidOxosuccinate
02

Mechanism of action

Not applicable—no drugs act directly on oxaloacetate. Some agents may alter its levels indirectly by modulating enzymes of the TCA cycle or gluconeogenesis.

03

Biological functions

Central intermediate in the citric acid cycle (Krebs/TCA cycle)Substrate for gluconeogenesisIntermediate in amino acid synthesis (e.g., aspartate)Involved in fatty acid synthesis and urea cycle
04

Disease associations

Metabolic disorders involving energy production or mitochondrial dysfunction
05

Safety considerations

Not applicable—oxaloacetate itself is an endogenous metabolite with no known direct safety concerns at physiological concentrations.
06

Biomarkers

No established clinical biomarkers use oxaloacetate directly for patient selection or efficacy monitoring.

Beyond the preview

Go deeper on Oxaloacetate (OAA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oxaloacetate (OAA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call